Centaurus Financial Inc. acquired a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 11,912 shares of the company’s stock, valued at approximately $1,531,000.
A number of other institutional investors have also recently added to or reduced their stakes in MKGAF. Frazier Financial Advisors LLC acquired a new position in Merck KGaA during the second quarter worth about $25,000. Rakuten Securities Inc. purchased a new stake in shares of Merck KGaA during the 2nd quarter worth approximately $27,000. Solstein Capital LLC purchased a new stake in shares of Merck KGaA during the 2nd quarter worth approximately $33,000. Delos Wealth Advisors LLC acquired a new stake in shares of Merck KGaA in the 2nd quarter worth approximately $33,000. Finally, Burk Holdings LLC acquired a new stake in Merck KGaA in the second quarter valued at $39,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Trading Down 3.9%
Shares of MKGAF stock opened at $158.15 on Friday. The firm has a 50-day moving average price of $163.21 and a 200 day moving average price of $148.95. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $20.44 billion, a price-to-earnings ratio of 24.14 and a beta of 0.96. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
